PMID- 22773877 OWN - NLM STAT- MEDLINE DCOM- 20121119 LR - 20211021 IS - 1083-351X (Electronic) IS - 0021-9258 (Print) IS - 0021-9258 (Linking) VI - 287 IP - 35 DP - 2012 Aug 24 TI - Identification of Akt-independent regulation of hepatic lipogenesis by mammalian target of rapamycin (mTOR) complex 2. PG - 29579-88 LID - 10.1074/jbc.M112.386854 [doi] AB - Mammalian target of rapamycin complex 2 (mTORC2) is a key activator of protein kinases that act downstream of insulin and growth factor signaling. Here we report that mice lacking the essential mTORC2 component rictor in liver (Lrictor(KO)) are unable to respond normally to insulin. In response to insulin, Lrictor(KO) mice failed to inhibit hepatic glucose output. Lrictor(KO) mice also fail to develop hepatic steatosis on a high fat diet and manifest half-normal serum cholesterol levels. This is accompanied by lower levels of expression of SREBP-1c and SREBP-2 and genes of fatty acid and cholesterol biosynthesis. Lrictor(KO) mice had defects in insulin-stimulated Akt Ser-473 and Thr-308 phosphorylation, leading to decreased phosphorylation of Akt substrates FoxO, GSK-3beta, PRAS40, AS160, and Tsc2. Lrictor(KO) mice also manifest defects in insulin-activated mTORC1 activity, evidenced by decreased S6 kinase and Lipin1 phosphorylation. Glucose intolerance and insulin resistance of Lrictor(KO) mice could be fully rescued by hepatic expression of activated Akt2 or dominant negative FoxO1. However, in the absence of mTORC2, forced Akt2 activation was unable to drive hepatic lipogenesis. Thus, we have identified an Akt-independent relay from mTORC2 to hepatic lipogenesis that separates the effects of insulin on glucose and lipid metabolism. FAU - Yuan, Minsheng AU - Yuan M AD - Center for Human Genetics and Diabetes Unit, Department of Medicine, Massachusetts General Hospital, and Department of Medicine, Harvard Medical School, Boston, MA 02114, USA. FAU - Pino, Elizabeth AU - Pino E FAU - Wu, Lianfeng AU - Wu L FAU - Kacergis, Michael AU - Kacergis M FAU - Soukas, Alexander A AU - Soukas AA LA - eng GR - K08 DK087941/DK/NIDDK NIH HHS/United States GR - K08DK087941/DK/NIDDK NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20120707 PL - United States TA - J Biol Chem JT - The Journal of biological chemistry JID - 2985121R RN - 0 (AKT1S1 protein, human) RN - 0 (Adaptor Proteins, Signal Transducing) RN - 0 (CRTC2 protein, human) RN - 0 (Crtc2 protein, mouse) RN - 0 (FOXO1 protein, human) RN - 0 (Fatty Acids) RN - 0 (Forkhead Box Protein O1) RN - 0 (Forkhead Transcription Factors) RN - 0 (Foxo1 protein, mouse) RN - 0 (GTPase-Activating Proteins) RN - 0 (Insulin) RN - 0 (Phosphoproteins) RN - 0 (SREBF1 protein, human) RN - 0 (SREBF2 protein, human) RN - 0 (Srebf1 protein, mouse) RN - 0 (Srebf2 protein, mouse) RN - 0 (Sterol Regulatory Element Binding Protein 1) RN - 0 (Sterol Regulatory Element Binding Protein 2) RN - 0 (TBC1D4 protein, human) RN - 0 (TSC2 protein, human) RN - 0 (Tbc1d4 protein, mouse) RN - 0 (Trans-Activators) RN - 0 (Transcription Factors) RN - 0 (Tsc2 protein, mouse) RN - 0 (Tuberous Sclerosis Complex 2 Protein) RN - 0 (Tumor Suppressor Proteins) RN - 0 (proline-rich Akt substrate, 40 kDa protein, mouse) RN - 97C5T2UQ7J (Cholesterol) RN - EC 2.7.11.1 (AKT2 protein, human) RN - EC 2.7.11.1 (Akt2 protein, mouse) RN - EC 2.7.11.1 (GSK3B protein, human) RN - EC 2.7.11.1 (Glycogen Synthase Kinase 3 beta) RN - EC 2.7.11.1 (Gsk3b protein, mouse) RN - EC 2.7.11.1 (Proto-Oncogene Proteins c-akt) RN - EC 2.7.11.26 (Glycogen Synthase Kinase 3) RN - IY9XDZ35W2 (Glucose) SB - IM MH - Adaptor Proteins, Signal Transducing/genetics/metabolism MH - Animals MH - Cholesterol/biosynthesis/genetics MH - Fatty Acids/genetics/metabolism MH - Forkhead Box Protein O1 MH - Forkhead Transcription Factors/genetics/metabolism MH - GTPase-Activating Proteins/genetics/metabolism MH - Gene Expression Regulation/physiology MH - Glucose/genetics/metabolism MH - Glycogen Synthase Kinase 3/genetics/metabolism MH - Glycogen Synthase Kinase 3 beta MH - Hep G2 Cells MH - Humans MH - Insulin/genetics/metabolism MH - Insulin Resistance/physiology MH - Lipogenesis/*physiology MH - Liver/*metabolism MH - Mice MH - Mice, Transgenic MH - Phosphoproteins/genetics/metabolism MH - Phosphorylation/physiology MH - Proto-Oncogene Proteins c-akt/genetics/*metabolism MH - Sterol Regulatory Element Binding Protein 1/genetics/metabolism MH - Sterol Regulatory Element Binding Protein 2/genetics/metabolism MH - Trans-Activators/genetics/*metabolism MH - Transcription Factors/genetics/*metabolism MH - Tuberous Sclerosis Complex 2 Protein MH - Tumor Suppressor Proteins/genetics/metabolism PMC - PMC3436168 EDAT- 2012/07/10 06:00 MHDA- 2012/12/10 06:00 PMCR- 2013/08/24 CRDT- 2012/07/10 06:00 PHST- 2012/07/10 06:00 [entrez] PHST- 2012/07/10 06:00 [pubmed] PHST- 2012/12/10 06:00 [medline] PHST- 2013/08/24 00:00 [pmc-release] AID - S0021-9258(20)63221-5 [pii] AID - M112.386854 [pii] AID - 10.1074/jbc.M112.386854 [doi] PST - ppublish SO - J Biol Chem. 2012 Aug 24;287(35):29579-88. doi: 10.1074/jbc.M112.386854. Epub 2012 Jul 7.